SMTL ID : 5ooh.1

Human biliverdin IX beta reductase: NADP/Erythrosin extra bluish ternary complex

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.20 Å

Oligo State

monomer

Ligands

1 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 32 residues within 4Å: Chain A: G.10, A.11, T.12, G.13, Q.14, T.15, G.16, L.33, R.35, R.39, G.53, D.54, V.55, L.56, L.74, L.75, G.76, T.77, R.78, V.86, M.87, C.109, T.110, S.111, A.112, V.128, H.132, P.151, P.152, H.153, I.154 Ligands: 9ZZ.3 37 PLIP interactions: 37 interactions with chain A Hydrophobic interactions: A:P.151, A:I.154, A:I.154 Hydrogen bonds: A:G.10, A:T.12, A:T.12, A:T.12, A:Q.14, A:Q.14, A:T.15, A:T.15, A:R.35, A:D.54, A:V.55, A:G.76, A:R.78, A:H.132, A:I.154 Water bridges: A:G.10, A:A.11, A:G.13, A:G.16, A:R.35, A:R.35, A:R.35, A:R.35, A:R.35, A:R.35, A:R.35, A:N.79, A:H.153, A:H.153 Salt bridges: A:R.35, A:R.39, A:R.78, A:R.78 pi-Cation interactions: A:R.35

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 4 residues within 4Å: Chain A: P.83, T.84, T.85, R.134 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:R.134, A:R.134 Water bridges: A:T.84, A:T.84

1 x 9ZZ: Erythrosin(Non-covalent)

9ZZ.3: 12 residues within 4Å: Chain A: Q.14, T.77, N.79, L.81, S.111, F.113, R.124, L.125, V.128, H.132, H.153 Ligands: NAP.1 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.125 Water bridges: A:Q.14, A:N.79, A:H.153, A:H.153, A:H.153, A:H.153 Salt bridges: A:H.153

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Nesbitt, N.M. et al., In silicoand crystallographic studies identify key structural features of biliverdin IX beta reductase inhibitors having nanomolar potency. J. Biol. Chem. (2018)

Release Date

2018-03-07

Peptides

Flavin reductase (NADPH): A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Flavin reductase (NADPH)

Related Entries With Identical Sequence